Table 6 Anticancer screening results of the synthesized compounds (T1T20)

From: Synthesis and biological evaluation of heterocyclic 1,2,4-triazole scaffolds as promising pharmacological agents

Compounds IC50 (μM) Compounds IC50 (μM)
T1 > 241.16 T12 > 206.80
T2 3.84 T13 > 202.61
T3 16.56 T14 128.25
T4 7.79 T15 > 217.55
T5 > 198.12 T16 169.25
T6 112.00 T17 > 217.55
T7 3.25 T18 > 208.02
T8 > 232.20 T19 > 226.91
T9 > 218.47 T20 > 247.15
T10 173.90 5-FU 25.36
T11 > 222.66 DMSO 1.50%
  1. Italics signifies the most active compound in comparison to the standard compound